2025 In Review - Stroke and Neurovascular Disorders

This episodes summarizes the most significant research developments in stroke and neurovascular medicine throughout the year 2025. It details a shift in acute care where tenecteplase has emerged as the favored drug for bridging therapy before clot removal. Conversely, the text highlights that mechanical intervention for smaller or distant vessel blockages may not offer benefits over standard medical care. Advances in rehabilitation emphasize the effectiveness of high-intensity physical training, while new studies explore pharmaceutical options for stabilizing brain aneurysms and utilizing inflammatory biomarkers for risk assessment. Collectively, these sources provide a comprehensive update on clinical trials, technological innovations, and evolving guidelines aimed at improving patient recovery and prevention.